• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉丁美洲多发性硬化症患者在 COVID-19 大流行期间的医疗保健变化。

Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic.

机构信息

Hospital Británico De Buenos Aires, Área de Enfermedades Desmielinizantes, Perdriel 74, Buenos Aires 1280, Argentina; Esclerosis Múltiple Argentina (EMA), Uriarte 1465, Buenos Aires 1414, Argentina.

Esclerosis Múltiple Argentina (EMA), Uriarte 1465, Buenos Aires 1414, Argentina.

出版信息

Mult Scler Relat Disord. 2021 Sep;54:103120. doi: 10.1016/j.msard.2021.103120. Epub 2021 Jun 30.

DOI:10.1016/j.msard.2021.103120
PMID:34243104
Abstract

BACKGROUND

The COVID-19 pandemic has resulted in uncertain access to medical treatment for people with multiple sclerosis (pwMS) all over the world. However, there is no data regarding its impact on access to health care of pwMS from Latin America.

OBJECTIVES

We investigated and described changes in health care delivery for pwMS from Latin America during the COVID-19 pandemic.

METHODS

PwMS from 18 patient organizations of the region completed a web-based survey hosted from May to October 2020.

RESULTS

A total of 602 pwMS completed the questionnaire. Changes in disease-modifying therapies (DMTs) use: 6.7% of pwMS on continuous DMTs claimed to stopped them; 14.1% of those on infusion therapies declared to postpone their dosing; 68.8% declared delaying the initiation of a DMT. Disruptions in accessing rehabilitation services were reported by 65.7%. Changes in laboratory and MRI monitoring were reported by 30% and 33%, respectively. In a multivariable-adjusted logistic regression model, changes in laboratory monitoring were significantly associated with increased odds of postponing MRI monitoring (OR 4.09 CI95% 2.79-6.00, p < 0.001).

CONCLUSIONS

The COVID-19 pandemic has disrupted all aspects of the routine care for pwMS from Latin America. Consequences are yet to be determined.

摘要

背景

COVID-19 大流行导致全世界多发性硬化症(pwMS)患者的医疗服务获取变得不确定。然而,关于 COVID-19 对拉丁美洲 pwMS 获得医疗保健的影响,尚无相关数据。

目的

我们调查并描述了 COVID-19 大流行期间拉丁美洲 pwMS 的医疗服务提供的变化。

方法

该地区 18 个患者组织的 pwMS 完成了一项于 2020 年 5 月至 10 月期间在网上进行的调查。

结果

共有 602 名 pwMS 完成了问卷。疾病修正治疗(DMT)使用的变化:6.7%的连续 DMT 使用者声称已停止使用;14.1%的输注疗法使用者宣布推迟剂量;68.8%的人表示推迟了 DMT 的开始。65.7%的人报告说在获得康复服务方面存在障碍。分别有 30%和 33%的人报告说实验室和 MRI 监测发生了变化。在多变量调整的逻辑回归模型中,实验室监测的变化与推迟 MRI 监测的几率增加显著相关(OR 4.09 CI95% 2.79-6.00,p<0.001)。

结论

COVID-19 大流行扰乱了拉丁美洲所有 pwMS 的常规护理。其后果还有待确定。

相似文献

1
Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic.拉丁美洲多发性硬化症患者在 COVID-19 大流行期间的医疗保健变化。
Mult Scler Relat Disord. 2021 Sep;54:103120. doi: 10.1016/j.msard.2021.103120. Epub 2021 Jun 30.
2
Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.2019冠状病毒病大流行对多发性硬化症患者护理及预后的间接影响:一项综合调查与保险理赔研究
Mult Scler Relat Disord. 2023 Dec;80:105085. doi: 10.1016/j.msard.2023.105085. Epub 2023 Oct 16.
3
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.多发性硬化症患者感染 COVID-19 的风险:一项病例对照研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2). doi: 10.1212/NXI.0000000000001141. Print 2022 Mar.
4
Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients.在一个大型拉丁美洲患者队列中,多发性硬化症护理服务获取和利用的障碍。
Mult Scler. 2021 Jan;27(1):117-129. doi: 10.1177/1352458519898590. Epub 2020 Jan 21.
5
How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey.COVID-19 大流行如何改变多发性硬化症的临床实践:全国性提供者调查结果。
Mult Scler Relat Disord. 2021 Jun;51:102913. doi: 10.1016/j.msard.2021.102913. Epub 2021 Mar 18.
6
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies.多发性硬化症和 COVID-19:评估风险认知、患者行为和获得疾病修正治疗的机会。
Mult Scler Relat Disord. 2022 Dec;68:104121. doi: 10.1016/j.msard.2022.104121. Epub 2022 Aug 17.
7
Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.COVID-19 大流行对 1000 多名多发性硬化症患者的医疗保健的影响:一项横断面研究。
Mult Scler Relat Disord. 2020 Nov;46:102512. doi: 10.1016/j.msard.2020.102512. Epub 2020 Sep 19.
8
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation.COVID-19 大流行对接受造血干细胞移植治疗的多发性硬化症患者疾病活动的影响。
Eur J Neurol. 2023 Oct;30(10):3362-3366. doi: 10.1111/ene.15989. Epub 2023 Aug 2.
9
Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients.新型冠状病毒抗体阳性多发性硬化症患者中疾病修正治疗的安全性。
Mult Scler Relat Disord. 2021 Apr;49:102754. doi: 10.1016/j.msard.2021.102754. Epub 2021 Jan 13.
10
Effect of COVID-19 on patient access to health services for noncommunicable diseases in Latin America: a perspective from patient advocacy organizations.COVID-19 对拉丁美洲非传染性疾病患者获得卫生服务的影响:来自患者权益倡导组织的观点。
Int J Equity Health. 2022 Apr 2;21(1):45. doi: 10.1186/s12939-022-01648-x.

引用本文的文献

1
Psychosocial Impact of the COVID-19 Pandemic Among Omanis with Multiple Sclerosis: Single Tertiary Center Experience.新冠肺炎疫情对阿曼多发性硬化症患者的社会心理影响:单一三级中心经验
Int J Environ Res Public Health. 2025 Aug 7;22(8):1236. doi: 10.3390/ijerph22081236.
2
Delay in seeking health care from community residents during a time with low prevalence of COVID-19: A cross-sectional national survey in China.在 COVID-19 低流行期间社区居民延迟寻求医疗保健服务:中国的一项横断面全国调查。
Front Public Health. 2023 Feb 21;11:1100715. doi: 10.3389/fpubh.2023.1100715. eCollection 2023.
3
Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?
新冠病毒疫苗接种后的血清转化:我们能否优化 CD20 治疗个体的保护反应?
Clin Exp Immunol. 2022 May 12;207(3):263-271. doi: 10.1093/cei/uxab015.
4
Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance.研究进展型多发性硬化症中的新冠肺炎需要全球协调、多学科和多利益相关方的方法——来自国际进展型多发性硬化症联盟的观点。
Mult Scler J Exp Transl Clin. 2022 May 3;8(2):20552173221099181. doi: 10.1177/20552173221099181. eCollection 2022 Apr-Jun.
5
Adherence to Therapy in Patients with Multiple Sclerosis-Review.多发性硬化症患者的治疗依从性-综述。
Int J Environ Res Public Health. 2022 Feb 15;19(4):2203. doi: 10.3390/ijerph19042203.
6
Healthcare Disruptions and Use of Telehealth Services Among People With Multiple Sclerosis During the COVID-19 Pandemic.COVID-19 大流行期间多发性硬化症患者的医疗中断和远程医疗服务使用情况。
Arch Phys Med Rehabil. 2022 Jul;103(7):1379-1386. doi: 10.1016/j.apmr.2021.12.028. Epub 2022 Jan 31.
7
Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America.拉丁美洲多发性硬化症患者中新冠病毒疫苗短期安全性评估。
Mult Scler J Exp Transl Clin. 2021 Nov 29;7(4):20552173211061543. doi: 10.1177/20552173211061543. eCollection 2021 Oct.